Lurbinectedin in extensive-stage small-cell lung cancer: a brief report of the IFCT-2105 LURBICLIN study.

Girard N, Guisier F, Swalduz A, Van Hulst S, Pichon E, Lavaud P, Greillier L, Tiotiu A, Madroszyk A, Bylicki O, Canellas A, Belmont L, Zysman M, Hauss PA, Godbert B, Audigier-Valette C, Lebreton C, Morin F, Westeel V

Open source

DOI: 10.1016/j.esmoop.2024.103968
Published: 2024 Dec
Container: ESMO open
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.esmoop.2024.103968,
  title = {Lurbinectedin in extensive-stage small-cell lung cancer: a brief report of the IFCT-2105 LURBICLIN study.},
  author = {Girard N and Guisier F and Swalduz A and Van Hulst S and Pichon E and Lavaud P and Greillier L and Tiotiu A and Madroszyk A and Bylicki O and Canellas A and Belmont L and Zysman M and Hauss PA and Godbert B and Audigier-Valette C and Lebreton C and Morin F and Westeel V},
  year = {2024},
  journal = {ESMO open},
  doi = {10.1016/j.esmoop.2024.103968},
  url = {https://doi.org/10.1016/j.esmoop.2024.103968}
}

RIS

TY  - JOUR
TI  - Lurbinectedin in extensive-stage small-cell lung cancer: a brief report of the IFCT-2105 LURBICLIN study.
AU  - Girard N
AU  - Guisier F
AU  - Swalduz A
AU  - Van Hulst S
AU  - Pichon E
AU  - Lavaud P
AU  - Greillier L
AU  - Tiotiu A
AU  - Madroszyk A
AU  - Bylicki O
AU  - Canellas A
AU  - Belmont L
AU  - Zysman M
AU  - Hauss PA
AU  - Godbert B
AU  - Audigier-Valette C
AU  - Lebreton C
AU  - Morin F
AU  - Westeel V
PY  - 2024
JO  - ESMO open
DO  - 10.1016/j.esmoop.2024.103968
UR  - https://doi.org/10.1016/j.esmoop.2024.103968
ER  -

APA

N, G., F, G., A, S., S, V. H., E, P., P, L., L, G., A, T., A, M., O, B., A, C., L, B., M, Z., PA, H., B, G., C, A., C, L., F, M., & V, W. (2024). Lurbinectedin in extensive-stage small-cell lung cancer: a brief report of the IFCT-2105 LURBICLIN study.. ESMO open. https://doi.org/10.1016/j.esmoop.2024.103968

Source records

pubmed · retrieved 2026-09-27T09:57:21.147Z